- Home
- IVA vs PHLT Comparison
IVA vs PHLT Comparison
Compare IVA & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- PHLT
- Stock Information
- Founded
- IVA 2011
- PHLT 1976
- Country
- IVA France
- PHLT United States
- Employees
- IVA N/A
- PHLT N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- PHLT Other Consumer Services
- Sector
- IVA Health Care
- PHLT Consumer Discretionary
- Exchange
- IVA Nasdaq
- PHLT Nasdaq
- Market Cap
- IVA 162.8M
- PHLT 187.1M
- IPO Year
- IVA 2020
- PHLT N/A
- Fundamental
- Price
- IVA $2.94
- PHLT $2.96
- Analyst Decision
- IVA Strong Buy
- PHLT
- Analyst Count
- IVA 4
- PHLT 0
- Target Price
- IVA $13.25
- PHLT N/A
- AVG Volume (30 Days)
- IVA 8.1K
- PHLT 134.3K
- Earning Date
- IVA 03-26-2025
- PHLT 03-12-2025
- Dividend Yield
- IVA N/A
- PHLT N/A
- EPS Growth
- IVA N/A
- PHLT N/A
- EPS
- IVA N/A
- PHLT N/A
- Revenue
- IVA $15,243,814.00
- PHLT $122,981,000.00
- Revenue This Year
- IVA $18.05
- PHLT $11.53
- Revenue Next Year
- IVA $46.74
- PHLT N/A
- P/E Ratio
- IVA N/A
- PHLT N/A
- Revenue Growth
- IVA N/A
- PHLT 8.12
- 52 Week Low
- IVA $1.53
- PHLT $2.26
- 52 Week High
- IVA $3.98
- PHLT $4.35
- Technical
- Relative Strength Index (RSI)
- IVA 53.75
- PHLT N/A
- Support Level
- IVA $2.70
- PHLT N/A
- Resistance Level
- IVA $3.10
- PHLT N/A
- Average True Range (ATR)
- IVA 0.18
- PHLT 0.00
- MACD
- IVA -0.02
- PHLT 0.00
- Stochastic Oscillator
- IVA 62.50
- PHLT 0.00
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc delivers payment integrity solutions for its healthcare payer clients.